Libya vs Saint Vincent and the Grenadines: Tuberculosis treatment success rate
Tuberculosis treatment success rate over time
- Libya
- Saint Vincent and the Grenadines
How they compare
Saint Vincent and the Grenadines currently reports 60.0% against 57.0% in Libya, a difference of 3.0%.
That makes Saint Vincent and the Grenadines's figure about 1.1 times Libya's.
The two have swapped places 8 times across 12 shared years of data; in 2004 it was Saint Vincent and the Grenadines ahead.
Libya ranks 184th and Saint Vincent and the Grenadines ranks 181st of 203 countries.
Across the 3 decades both report, Libya averaged higher in 2 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Libya | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.3% | 78.0% | 7.7% | Saint Vincent and the Grenadines |
| 2010s | 62.8% | 51.3% | 11.5% | Libya |
| 2020s | 63.7% | 55.3% | 8.3% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Libya or Saint Vincent and the Grenadines?
- Saint Vincent and the Grenadines, at 60.0% against 57.0% in Libya as of 2022.
- What is the difference in tuberculosis treatment success rate between Libya and Saint Vincent and the Grenadines?
- 3.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Libya and Saint Vincent and the Grenadines?
- 12 years are reported by both, from 2004 to 2022.
- How do Libya and Saint Vincent and the Grenadines rank globally for tuberculosis treatment success rate?
- Libya ranks 184th and Saint Vincent and the Grenadines ranks 181st of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).